Status:
UNKNOWN
Hematopoietic Stem Cell Transplantation From Human Leukocyte Antigen (HLA) Compatible Donor in Ewing Sarcomas and Soft Tissues Sarcomas
Lead Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Collaborating Sponsors:
S. Anna Hospital
Conditions:
Ewing
Soft Tissue Sarcoma
Eligibility:
All Genders
1-60 years
Phase:
PHASE2
Brief Summary
This is a perspective multicentric study for the treatment of patients aged equal or less than 60 years and submitted to an allogeneic hematopoietic stem cell transplantation from an HLA compatible re...
Eligibility Criteria
Inclusion
- Age 0-60 years.
- Performance status according to Karnofsky score \> 70%
- Normal liver function
- Normal renal function
- Normal cardiac function
- Informed consent
- Availability of an HLA compatible Donor
Exclusion
- Absence of at least one of the inclusion criteria
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00998361
Start Date
June 1 2009
End Date
June 1 2011
Last Update
October 20 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Oncology and Hematology Department, S. Orsola-Malpighi Hospital
Bologna, Italy, 40138